Abstract
With advances in immunosuppression, improvements in surgical technique, and use of extended criteria donors, patients previously considered ineligible for lung transplantation due to age are now undergoing these complex procedures with good outcomes. As the incidence of our aging population increases, we are likely to see more candidates over the age of 65 who are medically qualified for transplantation. Our study aims to quantify clinical graft outcome in terms of maximum % FEV1, the incidence and severity of PGD, and the overall survival of this patient population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
